Confronta i metodi
Esamina i metodi selezionati fianco a fianco; le righe che differiscono sono evidenziate.
| Indice SCORAD (SCORing Atopic Dermatitis)× | EASI (Eczema Area and Severity Index)× | |
|---|---|---|
| Campo | Dermatologia | Dermatologia |
| Famiglia | Process / pipeline | Process / pipeline |
| Anno di origine≠ | 1993 | 2001 |
| Ideatore≠ | European Task Force on Atopic Dermatitis (ETFAD) | Hanifin JM, Thurston M |
| Tipo | Clinician-rated | Clinician-rated |
| Fonte seminale≠ | Kunz B, Oranje AP, Labrèze L, et al. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology. 1997;195(1):10-19. DOI ↗ | Hanifin JM, Thurston M, Omoto M, et al. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. Experimental Dermatology. 2001;10(1):11-18. DOI ↗ |
| Alias | SCORAD Index | EASI Index |
| Correlati≠ | 3 | 2 |
| Sintesi≠ | The SCORAD is a comprehensive clinician-administered tool for measuring the extent and severity of atopic dermatitis (eczema). Developed by the European Task Force on Atopic Dermatitis in 1993, it combines objective clinical assessment with subjective symptom reporting. It is the gold standard for atopic dermatitis severity in clinical trials and dermatology practice. | The EASI is a structured, clinician-administered tool for assessing the extent and intensity of atopic dermatitis across the body. Developed by Hanifin and colleagues in 2001, it divides the body into four regions with weighted area factors, ensuring proportional contribution to total score. EASI has become the primary objective severity measure in atopic dermatitis clinical trials and is recommended by international regulatory authorities (FDA, EMA). |
| ScholarGateInsieme di dati ↗ |
|
|